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1. Introduction 
Pneumonectomy, the surgical removal of a lung, elicits a number of anatomical changes 
within the thoracic cavity that augments the diffusion capacity of the remaining lung. 
Pneumonectomy directs the entire cardiac output into the remaining lung and creates an 
empty hemithorax that results in a shift of the mediastinum toward the vacated thoracic 
compartment. In a number of experimental animal models, pneumonectomy initiates 
compensatory, regenerative growth of the remaining lung tissue that restores normal mass, 
structure and function. This growth process, called compensatory lung growth (CLG), is 
qualitatively similar across species, but differs with gender, age and hormonal status. CLG 
involves unique structure-function interactions not seen in solid organs. Little is known 
about the regenerative potential of human lungs. Although CLG has been reported in 
children after major lung resection, CLG in adults rarely occurs and remains a significant 
challenge. Mechanical feedback between the lung and thorax constitutes a major signal that 
sustains both post-natal lung development as well as post-pneumonectomy CLG. After 
pneumonectomy, increased mechanical stress and strain on the remaining lung induce 
adaptive responses to augment oxygen transport, including 1) recruitment of alveolar-
capillary reserves, 2) remodeling of existing tissue, and 3) regenerative growth of acinar 
tissue when strain exceeds a critical threshold. This chapter will discuss the clinical aspects 
of pneumonectomy and will primarily review cellular and molecular mechanisms of CLG 
via experimental pneumonectomy models, which offers powerful insights into regenerative 
organ growth. 
2. Clinical pneumonectomy 
2.1 Historical perspective 
Before the 1930s, all pneumonectomies in humans were fatal due primarily to 
complications such as hemorrhage and sepsis. Another major challenge was to perform 
lung surgery with an open pneumothorax. A significant step to solve this problem was 
taken in 1903 by Ferdinand Sauerbruch, who designed a negative pressure chamber that 
allowed a team of surgeons to operate within the open chest without collapse of the lung 
(Sauerbruch, 1953). Sauerbruch brought his machine to New York in 1908, where Willy 
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Meyer modified it to work with positive and negative pressure. Meyer successfully 
performed pulmonary resections in dogs in 1909 using suture closure of the bronchus and 
individual vessel ligation (Meyer, 1909), but he did not attempt his technique in humans. 
Years later, Quinby and Morse used a modification of this technique in dogs and showed 
that after pneumonectomy, the hemithorax fills with fluid and the remaining lung will 
shift to this empty side (Quinby & Morse, 1911). After the experimental use of 
endotracheal delivery of oxygen and anesthetics (Meltzer & Auer, 1909), Howard 
Lilienthal performed the first thoracotomy under endotracheal anesthesia at Mount Sinai 
Hospital (Lilienthal, 1910). He also had the largest published series of lobectomies, which 
he considered dangerous, reaching a mortality rate of 70% if more than one lobe was 
removed (Lilienthal, 1922). The first successful case of total pneumonectomy was 
described in 1931 by Roudolph Nissen in Berlin. The patient was a 12 year-old girl with 
trauma injury of the left chest (Naef, 1987). She recovered completely after two months, 
and Nissen was quoted saying that the occlusion of the pulmonary artery did not cause 
cardiopulmonary collapse as predicted 20 years earlier by Quinby and Morse. A year 
later, Cameron Haight was the first surgeon to perform a successful pneumonectomy in 
the west at the University of Michigan, USA (Haight, 1934). This time, a 13 year-old girl 
developed pneumonia in the left lung and subsequent pyopneumothorax. After a small 
bronchial fistula, she recovered 3.5 months later. On April 1933, Evarts Graham 
performed the first successful pneumonectomy for cancer disease in a 48 year-old patient 
with a squamous cell cancer of the left upper lobe bronchus that survived almost 30 years 
after surgery (Graham & Berck, 1933). In his paper, Clarence Crawford standardized the 
pneumonectomy technique used for many years, including the use of periscapular 
incision, individual vessel ligation, suture closure of the bronchus and a new rhythmic 
ventilatory technique (O'Shaughnessy & Crawford, 1938). In 1950, the introduction of a 
new double lumen tube allowed the ventilatory exclusion of the operated side (Bjork & 
Carlens, 1950). By the 1970s, a new technique changed the surgical method with the 
design of surgical staplers for lung resection. The first successful thoracic surgery 
performed using video assisted thoracic surgery (VDATS) was for treatment of 
pneumothorax in 1990. Shortly thereafter the first descriptions of pulmonary lobectomies 
and pneumonectomies appeared (Davies & Panasuk, 1992). There has been steady 
progress in thoracic surgery and pneumonectomy in particular through the years, with 
advances in knowledge of respiratory physiology, anesthetics and ventilation techniques, 
as well as more sophisticated methods of lung resection. These advancements have 
transformed pneumonectomy surgery from a “dangerous procedure” to become a very 
useful treatment for both malignant and non malignant diseases of the lung and airways.   
2.2 Indications and risk factors 
Pneumonectomy is known to be associated with high morbidity and mortality. However, in 
certain instances, it offers the only chance for a cure. The indications for pneumonectomy 
are usually classified in two major groups: pneumonectomy for benign disease and 
pneumonectomy for malignant disease. Due to the improvement of antimicrobial therapies 
and better control of inflammatory diseases, pneumonectomy for benign diseases is not a 
routine procedure in our times. The conditions considered in this group belong to several 
categories including inflammatory, traumatic, congenital and other miscellaneous 
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conditions (Conlan & Kopec, 1999). These conditions carry a high mortality rate in most 
cases, but some examples of non-malignant disease have an excellent cure rate. Indications 
for pneumonectomy in cases of bacterial or fungal infections include symptomatic patients 
with hemoptysis, productive cough or chronic empyema, as well as unilateral lung 
destruction documented by CT or bronchography (Blyth, 2000). In patients with pulmonary 
tuberculosis, pneumonectomy is indicated for either multidrug resistance disease or for 
complications or sequelae of tuberculosis infection. The most common fungal infection that 
requires pneumonectomy is produced by Aspergillum, which can produce severe infections 
with recurrent or massive hemoptysis in over 75% of patients (Conlan, et al., 1987). 
Pneumonectomy for trauma is uncommon, but is associated with high morbidity and 
mortality (66-75%). The most obvious indication of the procedure is the laceration of the 
lung and airways, which can produce massive hemorrhage and air leakage. Complications 
of congenital and other miscellaneous lung diseases, as well as completion pneumonectomy 
are rare indications for pneumonectomy, which can be associated with high mortality. 
Pneumonectomy for malignant disease has become the most common indication for lung 
resection today, which includes both primary lung tumors and metastatic lung disease. It is 
regarded as the only curative treatment for non small cell lung cancer (Shields, 1982) and 
also as an effective therapeutic option for pulmonary metastasis; however, these can be 
associated with high mortality (Spaggiari, et al., 1998).  
2.3 Morbidity and mortality 
Pneumonectomy is associated with a 38-59% rate of morbidity and a 30-day mortality 
ranging from 3-12%. Postoperative cardiac dysrhythmias (e.g., atrial fibrillation and 
supraventricular tachycardia) are relatively common complications occurring in 
approximately 20-40% of patients following pneumonectomy. Postpneumonectomy 
pulmonary edema (PPE) and acute respiratory distress syndrome (ARDS) occur in 4-7% of 
patients and are increasingly believed to be the same disease process. PPE/ARDS results in 
noncardiogenic pulmonary edema and is manifest by diffuse pulmonary infiltrates on chest 
radiograph combined with profound hypoxia and respiratory failure frequently requiring 
mechanical ventilation. One of the more devastating complications of pneumonectomy is an 
empyema involving the postpneumonectomy space. A postpneumonectomy empyema is 
usually associated with a bronchopleural fistula (BPF), which is a communication between 
the mainstem bronchial stump and the pleural cavity. The incidence of BPF and empyema 
ranges from 2-8%, but both complications are significantly more common in patients who 
undergo pneumonectomy for septic pulmonary disease (e.g., tuberculosis or fungal disease) 
(Deschamps, et al., 2001). Postpneumonectomy syndrome is a rare complication 
characterized by stridor, dyspnea and recurring pneumonia. Postpneumonectomy 
syndrome is more common following right pneumonectomy and results from severe 
shifting of the mediastinum and contralateral lung into the postpneumonectomy pleural 
space, which in turn leads to compression of the contralateral mainstem bronchus between 
the vertebral bodies and descending aorta (Kopec, et al., 1998). 
2.4 Physiological changes 
Pneumonectomy results in reduced lung function. Although residual volume (RV) declines 
after pneumonectomy, it decreases less than expected as a result of the hyperexpansion that 
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occurs in the remaining lung. Forced expiratory volume in one second (FEV1) and forced 
vital capacity (FVC) both typically decrease by 25-40%. Diffusion capacity usually decreases 
by less than 50% whereas PaO2 and PaCO2 typically remain unchanged from preoperative 
levels (Kopec, et al., 1998).  
3. Experimental CLG following pneumonectomy 
The removal of a lung entails profound mechanical, metabolic and vascular changes in 
response to the reduction in lung volume and the empty space in the hemithorax. These 
changes trigger a compensatory response in experimental models, known as CLG, which 
are directed toward reestablishing the normal rate of oxygen exchange capacity. This section 
describes a number of experimental animal models of CLG that are currently used to study 
this process, as well as a detailed evaluation of the CLG response in these models, including 
lung morphometry and imaging.  
3.1 Animal models 
In many animal models, pneumonectomy (or lobectomy) induces CLG of the remaining 
lung, resulting in rapid restoration of total lung volume, compliance, mass, DNA, protein, 
alveolar number, and normal lung cell populations. Pneumonectomy has proven to be a 
reliable model for characterizing the sources, mechanisms, and functional limits of the 
compensatory growth response after removal of lung tissue. Pulmonary resections in 
animals began in 1881 when it was documented that the remaining lung eventually 
expands to the same size as both lungs. Early animal studies established the basis for 
application of the procedure to humans, beginning in the 1900s. Cohn in 1939 first 
established mechanical forces as a major signal for the compensatory increase in lung 
mass following lobectomy. In the 1950s, Schilling detailed the well-preserved functional 
status in dogs that underwent removal in stages of up to nearly 70% of lung mass 
(Schilling, et al., 1958). The use of small animals (e.g. rabbit, rat, and mouse) from the 
1960s to the current day has had a great impact in uncovering the hormonal, cellular, and 
molecular responses to pneumonectomy (Bennett, et al., 1985; Buhain & Brody, 1973; 
Rannels, et al., 1979; Romanova, et al., 1967). Significant progress in understanding the 
cellular and molecular pathways of tissue regeneration in vertebrates were achieved using 
both transgenic mice and molecular biology techniques (Leuwerke, et al., 2002; Sakamaki, 
et al., 2002; Sakuma, et al., 2002). Functional compensation to pneumonectomy has been 
described mainly in dogs to define the limits of such compensation (Ravikumar, et al., 
2004; Takeda, et al., 1997). 
3.2 Alveolar growth 
Alveolar epithelial cells in pneumonectomized rats exhibit metabolic changes typical of 
accelerated cell growth. Studies in mice and rats indicate that type II epithelial cell 
hypertrophy, proliferation and differentiation into type I cells characterize CLG in a 
fashion similar to early postnatal lung growth and lung repair after injury (Kaza, et al., 
2002).  
The post-pneumonectomy CLG response is independent of the lobe or lobes removed in 
small animals; and all remaining lobes grow rapidly until normal total lung mass is 
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restored. Increases in lung volume after pneumonectomy parallel accumulation of tissue 
growth. However, the increase of growth in the remaining lobes is not uniform (Fernandez, 
et al., 2007). Development of sophisticated morphometric methods has permitted accurate 
analysis of lung volume and alveolar number, and studies indicate that new alveoli are 
formed during post-pneumonectomy CLG (Kaza, et al., 2002; Sakamaki, et al., 2002). In 
dogs, however, it appears that the CLG response is initiated after a certain threshold is 
achieved (removal of >50% of total lung mass) (Hsia, et al., 1994). Bronchoalveolar stem cells 
(BASC) have also been implicated in CLG. Their proliferation and differentiation into 
alveolar epithelial cells type II and I, contribute between 0-25% to the regenerative lung 
growth process (Nolen-Walston, et al., 2008). 
3.3 Vascular growth and angiogenesis 
Vascular growth and angiogenesis during CLG has not been well characterized. Stimuli 
known to initiate angiogenesis include hypoxia, inflammation, and mechanical factors 
such as shear stress and stretch. Our laboratory has shown that angiogenesis is necessary 
for successful CLG by demonstrating that angiogenesis inhibitors such as fumagillin or 
thalidomide prevented increased lung weight and volume after pneumonectomy (Maxey, 
et al., 2003). We have also shown that pneumonectomy induces arterial growth including 
the increase in length and number of branches of pulmonary arteries and that these 
changes are proportional to the amount of tissue removed (Le Cras, et al., 2005). When a 
bilobectomy was performed in rats (24% of lung tissue removed), the arterial area of the 
remaining lung increased by 26% compared to sham animals. Furthermore, when lung 
resection was more extensive (trilobectomy, 52%) we found that the increase in arterial 
area increased by 47% (Le Cras, et al., 2005). Other researchers have shown the effects of 
exogenous angiogenic factors, such as vascular endothelial growth factor (VEGF) in the 
mouse model. Additional VEGF therapy accelerated the CLG response, which was 
completed in only 4 days compared to 10 days in the pneumonectomy control group 
(Sakurai, et al., 2007). 
4. Initiation of CLG 
Several general hypotheses have been advanced to account for events that initiate the 
cellular and molecular changes that lead to CLG. Mechanical signals, transient hypoxia 
associated with thoracotomy, and elevated blood flow have been considered; however, no 
single event has been proven to account for the growth response. 
4.1 Mechanical forces  
After resection of the lung, increased inflation of the remaining lung and increased blood 
flow will induce stretch in both alveolar and endothelial structures. The displacement of 
the lung to the empty hemithorax is also a feature of CLG. These mechanical forces have 
an important role in initiating and regulating CLG as it was demonstrated when lateral 
displacement of the lung was restricted by the use of an inflatable prosthesis. This 
prevention of the mediastinal shift significantly limited mechanical lung strain, and CLG 
was thus significantly impaired by 30-60% (Hsia, et al., 2001). Another factor, increased 
alveolar inflation, was  also implicated when experiments using in vitro perfusion of lungs 
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with or without constant positive pressure ventilation (CPAP) of 20 cmH2O, 
demonstrated that lungs with increased inflation had cellular hyperplastic changes, such 
as elevated levels of cAMP and PKA activity, but perfusion alone did not account for 
these changes (Russo, et al., 1989). It is clear that CLG is very complex with multiple 
metabolic factors. Hyperinflation and stretch applied to the remaining lung after 
pneumonectomy are powerful signals to initiate CLG, and it is known that stretch of 
alveolar cells induces important changes associated with cell growth and septal 
formation, including signal transduction, protein turnover, growth factor production, 
proliferation, and apoptosis (Brody, 1975; Davies, et al., 1982; Fehrenbach, et al., 2008; 
Karl, et al., 1989). It appears that lung stress and strain generated after pneumonectomy, 
overlaid on a background of heightened developmental lung strain generated by the 
expanding thorax, intensifies the CLG responses. Importantly, minimizing post-
pneumonectomy strain of the remaining lung with space-occupying, inert material blunts 
the CLG response.    
4.2 Elevated blood flow 
Post-pneumonectomy changes in pulmonary blood flow have been considered as possible 
signals for CLG. Increased perfusion, reflecting elevated cardiac output to the remaining 
lung, likely causes physical distention of the pulmonary vasculature, resulting in a 
mechanical signal for lung growth and a concurrent increase in the growth factor and/or 
nutrient availability to the lung. It has been described that, after banding of the left caudal 
pulmonary artery in ferrets that reduced blood flow to the lung by 25%, CLG still occurred 
after pneumonectomy. However, the caudal lobes in the banded animals were 17% smaller 
than those of non-banded animals and tended to have lower protein content (McBride, et al., 
1992). In our laboratory, we have shown that after left pneumonectomy, increases in growth 
and proliferation were not uniform among the right lobes but were greater in the upper and 
cardiac lobes. These unequal changes coincided with a predominant vascular growth in the 
upper lobe, which received the highest fraction of relative blood flow (Fernandez, et al., 
2007). 
4.3 Hypoxia 
Hypoxia has been shown to stimulate alveolar growth either directly or via interaction 
with other signals. The effects of hypoxia after pneumonectomy were initially described 
in the rat model, where pneumonectomized rats that recovered at hypoxic levels showed 
significant increases in lung weight and volume indices, increased alveolar surface area 
and total alveolar numbers compared to normoxic and hyperoxic rats (Sekhon, et al., 
1993). Hypoxia-inducible factors (HIFs), which are activated in response to oxidative 
stress, hypoxia, injury, and physical forces, regulate transcription of genes involved in a 
wide array of functions including glycolysis, erythropoiesis, apoptosis, and angiogenesis. 
Most of these stressors are directly or indirectly associated with a change of intracellular 
oxygen tension, which leads to stabilization of the HIF-1 protein and increases the 
transcriptional activation of target genes. Elevated hypoxia-induced mitogenic factor 
(HIMF) and HIF-1 mRNA and protein expression has been documented during CLG, 
thus these pathways may play an important role in mediating CLG (Li, et al., 2005; Zhang, 
et al., 2006; Zhang, et al., 2007). 
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5. Molecular mediators of CLG   
The molecular mediators of CLG remain poorly understood. CLG involves regulated 
pathways of cell cycle activity, cell differentiation, synthesis and organization of connective 
tissue components, tissue remodeling, and angiogenesis. Studies in animals have led to 
several hypotheses that various pathways play a role in the induction of CLG including 
post-operative release of hormones and growth factors, as well as changes in cellular 
behavior. This section describes several important aspects of post-pneumonectomy CLG 
regulatory mechanisms.  
5.1 Hormones 
The most substantial evidence for hormonal regulation of CLG stems from investigations 
that involved surgical ablation of the adrenal glands, or adrenalectomy, which alone does 
not stimulate lung growth. Adrenalectomy performed prior to pneumonectomy increases 
the rate and extent of CLG above that observed in rats after pneumonectomy alone. This 
stimulatory effect on lung growth was blocked by daily doses of hydrocortisone acetate, 
evidenced by parameters such as dry lung weigh and DNA content, which were similar to 
the pneumonectomy group (Bennett, et al., 1985). This blocking effect was found only if 
the therapy was used continuously for the entire period after surgery (Rannels, et al., 
1987). A combination of dexamethasone, 8-bromo-3'-5'-cAMP and isobutylmethyl-
xanthine (DCI) has been successfully used to accelerate CLG in mice, represented by an 
increase in lung dry weight index and an increased number of alveoli by morphometric 
analysis. The effect of a single airway dose was enough to maintain the effect for the 
entire 28-day period of study. This effect seems to be modulated by thyroid transcription 
factor 1 (TTF-1), since its transient inhibition attenuated CLG (Takahashi, et al., 2011). 
Adrenal glucocorticosteroids seem to have a role in the modulation of the accelerated 
CLG initiated by pneumonectomy. Several lines of evidence suggest a possible role of 
growth hormone in the regulation of CLG. Significantly higher serum levels of growth 
hormone were detected in pregnant rats 3 days after pneumonectomy when compared 
with sham and unoperated rats (Khadempour, et al., 1992). In diabetic rats, which 
normally have greater levels of growth hormone and adrenal corticosteroids, 
pneumonectomy was accompanied by an increased dry lung weight index as well as 
higher elastin and collagen content, when compared to control pneumonectomy and sham 
rats (Ofulue & Thurlbeck, 1995). Following pneumonectomy, rats implanted with a 
subcutaneous growth hormone-secreting tumor (MtTF4) underwent a CLG response 
similar to non-tumor-bearing controls; however, lung growth in MtTF4 rats was 
associated with a greater lung volume.  
5.2 Growth factors 
There is ample evidence that growth factors regulate CLG, and the production of many 
growth factors is known to be sensitive to mechanical strain. Each growth factor modulates 
different aspects of cellular growth, but any one growth factor cannot recapitulate the entire 
CLG response, and there is much functional overlap among growth factors. Our laboratory, 
among others, has demonstrated important roles for epidermal growth factor (EGF), 
hypoxia-induced mitogenic factor (HIMF), keratinocyte growth factor (KGF) and retinoic 
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acid in CLG. Other growth factor signaling pathways have been found to be activated after 
PNX including insulin-like growth factor-1 (IGF-1), hepatocyte growth factor (HGF), 
erythropoietin receptor, and hypoxia-inducible factor-1 (HIF-1). These growth factors will 
be discussed below. 
5.2.1 Epidermal growth factor (EGF)  
It is been shown that EGF via its receptor (EGFR) plays a role in prenatal and postnatal lung 
development. Its actions involve the synthesis of surfactant precursors and the 
differentiation of type 2 epithelial cells. Using a pig lobectomy model, our laboratory 
demonstrated an upregulation of EGFR expression two weeks after lobectomy, which 
coincided with an increased alveolar cell proliferation index of the remaining lung. At 3 
months after surgery, there was an increase in the lung protein/DNA ratio in the lobectomy 
group compared to controls (Kaza, et al., 2001; Kaza, et al., 2002). We also have documented 
the effects of EGF in CLG using a rodent pneumonectomy model. When exogenous EGF 
was administered to rats after pneumonectomy, it caused significantly higher lung weight 
and volume indices when compared to pneumonectomy control animals. We also detected 
an upregulation of EGFR after exogenous EGF supplementation (Kaza, et al., 2000), 
suggesting that the upregulation of EGF signaling is a feature of this process and is capable 
of modulating post-pneumonectomy GLG. 
5.2.2 Erythropoietin (EPO) 
Erythropoietin (EPO) actions have been classically associated with the induction of 
erythropoiesis; however, organ specific EPO receptor (EPOR) signaling is also involved in 
development, angiogenesis and organ growth. Researchers have shown that EPOR is 
upregulated both during postnatal lung maturation and during CLG in adult dogs (Foster, 
et al., 2004). Furthermore, they demonstrated an upregulation of one of its upstream 
activators, HIF-1, during the same processes. Using an in vitro system, the same group 
showed that upregulation of HIF-1 in cultured HEK-293 cells also caused the upregulation 
of endogenous EPOR expression (Zhang, et al., 2006). This also provided evidence of a 
possible role of EPOR in CLG after pneumonectomy.  
5.2.3 Hepatocyte growth factor (HGF) 
HGF is known to selectively stimulate epithelial and endothelial cells, and the major 
sources for HGF in the lung are macrophages, fibroblasts, and endothelial cells. The 
increase of serum HGF during the first week after major lung resections in humans has 
been documented (Dikmen, et al., 2006; Sugahara, et al., 1998). A more comprehensive 
study of the role of HGF in CLG was performed using a mouse pneumonectomy model 
(Sakamaki, et al., 2002). In this study, the authors demonstrated an increased level of both 
lung mRNA and protein expression of HGF after pneumonectomy, and serum HGF levels 
were also higher when compared to sham operated animals. These findings were 
accompanied by an increased proliferation index of alveolar and airway epithelial cells, 
which peaked at day 5 after surgery. They also detected an upregulation of the HGF 
receptor (c-Met) at day 3 post-pneumonectomy. In addition, injections of HGF twice daily 
enhanced the proliferative response of these cells as well as increased lung weight index 
at day 3 when compared to controls. Use of a neutralizing antibody against HGF resulted 
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in the inhibition, although incomplete, of the increase in lung weight and DNA synthesis 
observed. Another interesting study evaluated the effects of CLG in a rat model of 
elastase-induced emphysema, with transfection of the human HGF cDNA into the lung 
(Shigemura, et al., 2005) or implantation of adipose tissue-derived stromal cells (ASCs), 
which produce a large amount of angiogenic factors including HGF (Shigemura, et al., 
2006). Therapy with gene transfection was performed using the hemagglutinating virus of 
Japan (HVJ) envelope-plasmid complex. In the HGF- and ASC-treated animals, increased 
levels of both exogenous and endogenous HGF were detected; and furthermore, HGF 
enhanced the CLG response by increasing lung cell proliferation and improving 
functional parameters. Taken together, these studies provide strong evidence for a role of 
HGF in the proliferative responses during CLG. 
5.2.4 Hypoxia-induced mitogenic factor (HIMF) 
In a collaborative study, we demonstrated the role of HIMF in the context of CLG (Li, et al., 
2005). The mRNA and protein expression of HIMF, which is known by its mitogenic and 
angiogenic properties, was upregulated after pneumonectomy (days 3-14) when compared 
to sham operated mice. The elevated HIMF expression also coincided with an increase in 
cell proliferation index in lungs of these animals. HIMF expression after pneumonectomy 
was mainly detected in airway epithelial, endothelial and type 2 epithelial cells. 
Intratracheal instillation of exogenous HIMF increased the proliferative activity in these 
cells, documenting its mitogenic properties and establishing its role in CLG. 
5.2.5 Hypoxia-inducible factor-1α (HIF-1α) 
Researchers have shown that HIF-1 expression is upregulated both during postnatal lung 
maturation and during adult CLG in dogs and that this coincides with the upregulation of 
one of its downstream targets, EPOR. In vitro experiments also provided evidence that 
upregulation of HIF-1 in cultured HEK-293 cells triggers the upregulation of endogenous 
EPOR expression (Zhang, et al., 2006). Another study found that lung expansion is a major 
contributor to the activation and stabilization of HIF-1. Acute deflation of prosthesis in the 
chest cavity of pneumonectomized dogs triggered the increase of both HIF-1 and several 
HIF-1 targets including EPOR and VEGF compared to non-deflated animals. They 
concluded that these increases did not depend on hypoxia but instead were due to stretch-
related signals after lung resection (Zhang, et al., 2007).  
5.2.6 Insulin-like growth factor-I (IGF-I) 
IGF-1, its receptor and binding proteins are naturally expressed in the lung during 
development, and IGF-1 is known to contribute to the regulation of postnatal lung cell 
proliferation. Researchers have shown that 2 and 6 days after pneumonectomy in rats, the 
bronchoalveolar lavage fluid from these animals demonstrated significantly increased 
mitogenic activity when applied in vitro to fibroblasts compared with controls. 
Importantly, such activity was partially inhibited by the use of neutralizing antibody 
against IGF-1, and the levels of IGF-1 were elevated by 100% at day 2 after 
pneumonectomy (McAnulty, et al., 1992). In a separate study, IGF-1 mRNA expression 
was again significantly increased after 21 days post-pneumonectomy in a model of 
neonatal CLG in lambs (Nobuhara, et al., 1998). 
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5.2.7 Keratinocyte growth factor-I (KGF) 
KGF has been shown to play an important role in alveolar epithelial cell proliferation and 
lung development. In our laboratory, exogenous KGF administered to rats after 
pneumonectomy further enhanced several parameters of CLG compared to control animals. 
Changes in lung weight index, lung volume index as well as morphometric parameters were 
accompanied by a significant increase in pulmonary cell proliferation index, providing the 
first evidence for a role of KGF in CLG (Kaza, et al., 2002). A more recent study corroborated 
our findings where epithelial cell proliferation was further enhanced after in vivo 
transfection of a KGF cDNA vector in a model of CLG in rats, confirming KGF as an 
important lung mitogenic factor (Matsumoto, et al., 2009).  
5.2.8 Retinoic acid  
Retinoic acid, a metabolite of vitamin A, has been implicated in normal lung development 
and cell proliferation. Our laboratory described the effects of exogenous retinoic acid 
during CLG in a rat model (Kaza, et al., 2001). At 10 and 21 days after pneumonectomy, 
lung weight, lung volume and cellular proliferation indices were all significantly 
augmented in rats that received exogenous retinoic acid versus vehicle controls. 
Interestingly, we also found that pulmonary expression of EGFR was upregulated in 
lungs after retinoic acid treatment, uncovering a possible relationship between these two 
important growth factors in CLG. Another similarly designed study corroborated our 
results several years later (Karapolat, et al., 2008); however, these effects did not translate 
into functional recovery according to studies developed using the dog model (Dane, et al., 
2004).   
5.2.9 Vascular endothelial growth factor (VEGF)  
Angiogenesis, the formation of new blood vessels, is a critical step in normal organ 
development and in abnormal processes such as tumor growth and metastasis. In the 
lung, alveolar growth and angiogenesis should occur concurrently in order to result in 
normal organ development or regeneration. One of the most important angiogenic growth 
factors, VEGF has been studied in CLG, revealing its importance in this regenerative 
process. Researchers described the effects of exogenous VEGF in the mouse model, 
showing that exogenous VEGF therapy accelerated the CLG response, which was 
completed in only 4 days compared to 10 days in control animals. However, these effects 
could not be blocked by the use of either VEGF receptor inhibitors or neutralizing 
antibodies (Sakurai, et al., 2007). Another study associated lung expansion and other 
signaling pathways to VEGF. The acute deflation of prosthesis in the chest cavity of 
pneumonectomized dogs triggered the increase of HIF-1α and its targets EPOR and VEGF 
compared to non-deflated animals, showing the interaction between these signals in the 
regulation of CLG (Zhang, et al., 2007). A recent paper studied the modulation of different 
VEGF isoforms along with its receptor during CLG, where VEGF 188 mRNA expression 
was decreased compared to sham animals and VEGF 164 and VEGF 120 mRNAs 
increased during days 1 and 3 respectively, describing what they believe is the 
recapitulation of the pattern of expression for these isoforms in the fetal lung (Jancelewicz, 
et al., 2010). A brief summary of evidence for the role of growth factors in CLG is shown 
in Table 1. 
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Growth Factor Evidence Species 
EGF • Pneumonectomy increased EGFR lung expression. 
• Exogenous EGF enhances CLG. 
Rat, pig 
Rat 
EPOR • Pneumonectomy increased EPOR lung expression. Dog 
HGF • Pneumonectomy increased serum HGF, along with 
expression of HGF and its receptor (c-Met) in lung. 
• Exogenous HGF enhances CLG. 
• Neutralizing antibody against HGF attenuate CLG.  
Mouse 
Mouse, 
rat 
Mouse 
HIMF • Pneumonectomy increased lung HIMF mRNA and 
protein expression. 
• Exogenous HIMF enhances proliferation. 
Mouse 
HIF-1α • Pneumonectomy increased lung HIF-1 mRNA and 
protein expression. 
• Lung expansion modulates HIF-1 expression. 
Dog 
IGF-1 • Pneumonectomy increased lung IGF-1 mRNA and 
protein expression. 
• Neutralizing antibody against IGF-1 attenuate    
mitogenic in vitro effects. 
Lamb, rat 
 
Rat 
KGF • Pneumonectomy increased lung KGF mRNA. 
• Exogenous KGF enhances CLG. 
Rat 
Retinoic Acid • Exogenous retinoic acid enhances CLG. 
• Exogenous retinoic acid induces EGFR. 
Rat 
 
VEGF • Pneumonectomy increased lung VEGF 164 and 120 
mRNA expressions. 
• Exogenous VEGF accelerates CLG. 
Mouse 
Table 1. Summary of potential roles of growth factors in CLG. 
5.3 Transcription factors 
Pneumonectomy induces shear stress in the lung, and several key transcription factors 
provide links between shear-mediated signaling and CLG. Mitogen-activated protein 
kinases (MAPKs), composed of extracellular signal-regulated kinases (ERKs), c-jun NH2-
terminal kinases (JNKs), and p38 MAPKs, play a critical role in cell differentiation, growth 
and apoptosis and the regulation of various transcription factors and gene expression. One 
of the first reports about stretch-induced early gene expression demonstrated that in as early 
as 30 minutes post-pneumonectomy in rats, c-fos and JunB are significantly increased. These 
results were also reproduced when in vitro ventilation-perfusion was used (Gilbert & 
Rannels, 1998). Using array technology, researchers have also shown significant increases in 
six different transcription factors as early as 6 hours after pneumonectomy in mice including 
Erg-1 and Nur77, all of which have important roles in vascular biology, development and 
stress response (Landesberg, et al., 2001). In addition, a more recent paper found an 
important role for thyroid transcription factor 1 (TTF-1) in CLG (Takahashi, et al., 2010). 
These investigators detected a significant increase of TTF-1 expression 12 hours after 
pneumonectomy with TTF-1 expression primarily observed in cells of the alveolar ducts. 
When TTF-1 was repressed using small inhibitory RNAs (siRNAs), the CLG response was 
also temporally delayed.  
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5.4 Telomerase 
Telomerase is an important enzyme for DNA repair and contributes to cell maintenance. 
Telomerase prevents the excess shortening of telomeres, and it has been demonstrated 
that telomerase is active in proliferating cells in a number of organs, including the lung. In 
humans, mutations of the telomerase gene results in a pathological condition known as 
idiopathic pulmonary fibrosis (IPF). Its role in preserving lung epithelial integrity was 
demonstrated in an experimental model in mice, where telomerase deficiency resulted in 
a reduction in the number and integrity of type 2 alveolar epithelial cells (AEC2) (Lee, et 
al., 2009). It is important to know that this defect may not be apparent in early 
generations, but after progressive inbreeding, it was possible to establish the deficiency in 
AEC2s as well as in bronchoalveolar stem cell (BASC) populations in the lung, due to 
shortening of the telomeres. In a recent study, the importance of telomerase was 
demonstrated for CLG after pneumonectomy using telomerase deficient mice from second 
(F2), third (F3) and fourth (F4) generation animals (Jackson, et al., 2011). In wild-type 
mice, the activity of telomerase was found to increase in isolated AEC2s up to 3.5-fold 
during post-pneumonectomy days 3 and 7. In addition, the total number of AEC2s and 
BASCs also increased at day 3 after pneumonectomy. However, pneumonectomy resulted 
in diminished CLG in F3 telomerase null animals, expressed as failure to induce an 
increase in lung mass by day 7 after pneumonectomy. In addition, the number of AEC2s 
and BASCs did not increase during the initial period after pneumonectomy when 
compared to wild-type mice. The normal CLG, both in lung mass and AEC2 numbers, in 
wild-type mice was also accompanied by an elevation in the proliferation marker Ki-67, 
early growth response gene (Egr-1) and repair transcription factors such as ERK 1/2, 
which were not observed in telomerase null mice. The authors concluded that telomerase 
deletion produces an attenuated CLG response after pneumonectomy by arresting cell 
growth and inducing DNA damage.  
6. Conclusion 
The extent of CLG in humans following pneumonectomy or lobectomy is incompletely 
investigated, but a number of long-term physiological studies suggest, however, that some 
degree of CLG may occur, especially in children (Nakajima, et al., 1998; Nonoyama, et al., 
1986). The ability to manipulate the gain/loss of function for a particular gene in 
experimental animals has begun to provide a more detailed understanding of the molecular 
mediators and the pathologic consequences of CLG. Also, recent developments in cell 
therapy of diseased lungs with the use of adipose stem cells are indeed promising 
(Shigemura, et al., 2006). An important long-term goal of research into mechanisms of CLG 
is to generate knowledge that will allow the induction of alveolar regeneration or that 
rescues failed alveologenesis in humans. Such understanding will facilitate the development 
of therapies for the management of end-stage lung disease, lung volume reduction surgery, 
and transplantation. The potential clinical applications of this research are great. Specific 
examples of patients who would clearly benefit from lung regenerative therapies include 
chronic obstructive pulmonary disease (COPD), emphysema, pulmonary hypertension, 
bronchopulmonary dysplasia (BPD), as well as premature infants whose lungs are too 
underdeveloped to support life. 
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